These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7861244)

  • 1. Investigations into the actions of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1(7-36)amide on lipoprotein lipase activity in explants of rat adipose tissue.
    Knapper JM; Puddicombe SM; Morgan LM; Fletcher JM
    J Nutr; 1995 Feb; 125(2):183-8. PubMed ID: 7861244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose dependent insulinotropic polypeptide and glucagon-like peptide-1(7-36)amide: effects on lipoprotein lipase activity.
    Knapper JM; Puddicombe SM; Morgan LM; Fletcher JM; Marks V
    Biochem Soc Trans; 1993 May; 21(2):135S. PubMed ID: 8359389
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7-36) amide, on fatty acid synthesis in explants of rat adipose tissue.
    Oben J; Morgan L; Fletcher J; Marks V
    J Endocrinol; 1991 Aug; 130(2):267-72. PubMed ID: 1919397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal changes, caused by insulin and glucagon, of adipose tissue lipoprotein lipase in rats in vitro.
    Murase T; Tanaka K; Iwamoto Y; Akanuma Y; Kosaka K
    Horm Metab Res; 1981 Apr; 13(4):212-3. PubMed ID: 7016708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-I-(7-36) on insulin secretion.
    Jia X; Brown JC; Ma P; Pederson RA; McIntosh CH
    Am J Physiol; 1995 Apr; 268(4 Pt 1):E645-51. PubMed ID: 7733263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of insulin, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) secretion by octreotide has no effect on post-heparin plasma lipoprotein lipase activity.
    Ranganath LR; Beety JM; Morgan LM
    Horm Metab Res; 1999 Apr; 31(4):262-6. PubMed ID: 10333081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the insulinotropic activity of glucagon-superfamily peptides in rat pancreas perfusion.
    Suzuki S; Kawai K; Ohashi S; Watanabe Y; Yamashita K
    Horm Metab Res; 1992 Oct; 24(10):458-61. PubMed ID: 1464409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic stimulatory effect of glucagon-like peptide-1 (7-36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas.
    Fehmann HC; Göke B; Göke R; Trautmann ME; Arnold R
    FEBS Lett; 1989 Jul; 252(1-2):109-12. PubMed ID: 2668027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide I and glucose-dependent insulinotropic polypeptide stimulate Ca2+-induced secretion in rat alpha-cells by a protein kinase A-mediated mechanism.
    Ding WG; Renström E; Rorsman P; Buschard K; Gromada J
    Diabetes; 1997 May; 46(5):792-800. PubMed ID: 9133546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric inhibitory polypeptide enhanced lipoprotein lipase activity in cultured preadipocytes.
    Eckel RH; Fujimoto WY; Brunzell JD
    Diabetes; 1979 Dec; 28(12):1141-2. PubMed ID: 510813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistin is a key mediator of glucose-dependent insulinotropic polypeptide (GIP) stimulation of lipoprotein lipase (LPL) activity in adipocytes.
    Kim SJ; Nian C; McIntosh CH
    J Biol Chem; 2007 Nov; 282(47):34139-47. PubMed ID: 17890220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric inhibitory polypeptide: a gut hormone with anabolic functions.
    Beck B
    J Mol Endocrinol; 1989 May; 2(3):169-74. PubMed ID: 2665779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearing-factor lipase in adipose tissue. Studies with puromycin and actinomycin.
    Wing DR; Robinson DS
    Biochem J; 1968 Feb; 106(3):667-76. PubMed ID: 4295776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop.
    Roberge JN; Brubaker PL
    Endocrinology; 1993 Jul; 133(1):233-40. PubMed ID: 8319572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 [7-36 amide] infused at near-physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    Digestion; 1992; 52(3-4):214-21. PubMed ID: 1459356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of glucose and insulin on the activation of lipoprotin lipase and on protein-synthesis in rat adipose tissue.
    Parkin SM; Walker K; Ashby P; Robinson DS
    Biochem J; 1980 Apr; 188(1):193-9. PubMed ID: 6996676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lipoprotein lipase of white adipose tissue. Changes in the adipocyte cell-surface content of enzyme in response to extracellular effectors in vitro.
    Al-Jafari AA; Cryer A
    Biochem J; 1986 Aug; 238(1):239-46. PubMed ID: 3541907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent-insulinotropic peptide but unaffected by glucose.
    Damholt AB; Buchan AM; Kofod H
    Endocrinology; 1998 Apr; 139(4):2085-91. PubMed ID: 9528997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness.
    Delmeire D; Flamez D; Moens K; Hinke SA; Van Schravendijk C; Pipeleers D; Schuit F
    Biochem Pharmacol; 2004 Jul; 68(1):33-9. PubMed ID: 15183115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.